8 LUCEY ET AL .
BRIEF DEFINITIVE REPORT CSF (rhGM-CSF) (Genzyme, Boston, MA) on a monolayer of Swiss 3T3 fibroblasts, as described (17) . 1 .5 ml of fresh RPMI/rhGM-CSF were exchanged on days 2, 5, and 7 . CD4 expression on 10 4 cells was measured by flow cytometry (FACScan ; Becton Dickinson & Co., Mountain View, CA) with fluoresceinated anti-Leu-3a and -b (Becton Dickinson & Co.) and is expressed relative to a subclass control mAb . Eosinophil granule staining and nuclear morphology were evaluated by staining with fast green/neutral red and phloxine/methylene blue (13) . The absence of both lymphocytes and monocytes was confirmed by finding no more than background cellular staining by flow cytometric analyses with two fluoresceinated mAbs (anti-Leu-1, for CD5 on T cells and anti-Leu-M3 for monocytes/macrophages ; both from Becton Dickinson & Co .) . Biosynthetic Labeling of Eosinophil CD4. Eosinophils (8 .7 x 10', >99% eosinophils, 97% CD4') from a hypereosinophilic donor were harvested after 15 d of culture with rhGM-CSF and 3T3 fibroblasts, as described above. After washing in PBS eosinophils were resuspended in 1 ml HBSS and pulse labeled for 1 h with 700 gCi "S-methionine (Tran"S-label ; ICN Radiochemicals, Costa Mesa, CA) at 37°C, 5% C0 2 . Eosinophils were lysed in RIPA buffer (50 mM Tris, pH 8 .0, 150 mM NaCl, 1 % sodium deoxycholate, 1 % Triton X-100, 0 .1 % SDS) for 10 min at 4°C . After centrifugation (16,000 g, 15 min, 4°C), the soluble extract was immunoabsorbed in parallel with 0 .6 gg control antibody (UPC 10 ; Cappel Laboratories, Malvern, PA) or 0 .5 pg anti-OKT4 or anti-OKT4A (both from Ortho Diagnostic Systems, Inc., Westwood, MA) . After 2 h at 4°C, 50 pl protein A-Sepharose (Genzyme) was added for 45 min . Protein A-Sepharose complexes were washed three times with RIPA buffer and once with water and then boiled for 3 min in Laemmli sample buffer (18) . Proteins were resolved on SDS-PAGE gels (1°jo SDS, 10°Jo polyacrylamide) and visualized by fluorography of gels for 3 d at -70°C with Kodak X-GMAT film .
HIV-1 GP120 Binding. Cells from donor 1 were maintained in culture for 10 d with 50 pM rhGM-CSF/3T3 fibroblasts, as described above, and then collected (>99% eosinophils, >99% viable) . 1 .5 x 10' eosinophils in 1 ml of Ca", Mgt'-free HBSS were incubated at 37°C for 30 min with or without 10 gg of partially purified HIV-1 gp120, which had been immunoaffinity purified from culture fluids of HTLVIIIB-infected H9 cells . Eosinophils were pelleted, resuspended, and stained for 30 min at 4°C with 10 pl of anti-OKT4, anti-OKT4A (both from Ortho Diagnostic Systems, Inc .) or control UPC-10 (Cappel Laboratories) mAb. After two washes in HBSS with 0 .1 % BSA, cells were stained at 4°C for 30 min with fluoresceinated goat anti-mouse Ig (Becton Dickinson & Co .), washed twice with HBSS/0 .1% BSA, fixed with 1% paraformaldehyde, and analyzed by flow cytometry.
Results and Discussion
Eosinophils were isolated from the blood of nine donors (Table 1) . After depletion of mononuclear leukocytes and further purification, eosinophil-enriched leukocytes were incubated with fluoresceinated mAbs anti-Leu-3a and -b, which recognize epitopes on CD4 . By flow cytometry CD4 expression was demonstrable on the eosinophilenriched cells (Table I The eosinophil-enriched cells were placed in culture with rhGM-CSF on monolayers of 3T3 fibroblasts, and residual contaminating neutrophils died in the early days of culture, as previously reported (17) . By day 5 of culture >99 ,70 of all cells, except the fibroblasts, were eosinophils, and these eosinophils from all donors expressed Eosinophils from five eosinophilic and four normal donors were isolated and enriched to the percentages indicated before culture on day 0 . Eosinophils were maintained in culture with rhGM-CSF and 3T3 fibroblasts, as described in Materials and Methods . CD4 expression on 104 cells was measured by flow cytometry and is expressed relative to a subclass control mAb . * Day of culture . CD4 (Table I, Fig. 1 ). The lack of other contaminating leukocytes during culture was established by cytochemical staining and again by an absence of staining with the fluoresceinated anti-T cell and anti-monocyte/macrophage mAbs . Cultured eosinophils were pulse labeled with 35 S-methionine, and detergent extracts of these cells were immunoprecipitated with anti-OKT4 and anti-OKT4A, which react with different epitopes on CD4 (19, 20) . Both mAbs precipitated a 35 S-labeled 55-kD polypeptide (Fig. 2) . In separate immunoprecipitation studies with anti-OKT4, the CD4 precipitated from eosinophils comigrated with 35 S-labeled PBMC CD4 on SDS-PAGE (data not shown) with an Mr identical to that previously determined for CD4 on monocytes and lymphocytes (2) . Immunoprecipitation from eosinophils of metabolically-labeled molecules with an Mr of 55,000 confirmed the identity of the protein recognized by the anti-CD4 mAbs and also established that mature eosinophils, often considered end-stage terminally differentiated cells, retain the capacity to synthesize new proteins, including CD4. Like the CD4 molecule on human lymphocytes and monocytes, eosinophil CD4 also binds the HIV-1 gp120 envelope glycoprotein . HIV-1 gp120 competitively blocked the staining of eosinophils with mAb OKT4A, which recognizes a gp120 binding epitope on CD4, but not the staining with OKT4, an mAb to a region of CD4 not involved in gp120 binding (11, 19, 20) (Fig, 3) . Eosinophils staining with anti-OKT4A decreased from 85.4% to 26.6% after gp120 binding but anti-OKT4 staining was unchanged from 90 .8% to 89.6% with gp120. Similar results were obtained at two concentrations of gp120 (10 and 17 wg/ml) . OKT4Ã ,OKT4 FIGURE 3.
HIV-1 gp120 binding to CD4' eosinophils. A represents eosinophils not incubated with gpl20 and B represents those that were incubated with gpl20. Staining with mAb OKT4A, which recognizes a gpl20 binding epitope on CD4, and with OKT4, an mAb to a region of CD4 not involved in gp120 binding, are presented relative to a subclass control mAb. Eosinophils synthesized a 55-kD CD4 polypeptide immunoprecipitable with two anti-CD4 mAbs . Eosinophil CD4 bound HIVI gp120 as assessed by competition for anti-OKT4A, but not anti-OKT4, mAb binding . Eosinophils, normally rich in gastrointestinal and genitourinary tract tissues, increase in numbers in patients with metazoan parasitic infections . In these sites and diseases, CD4 expression by eosinophils may be pertinent to their immunologic functions and could make these cells susceptible to HIV infection .
